Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review

<p>Abstract</p> <p>Background</p> <p>Prostate specific antigen (PSA) testing is widely used, but guidelines on follow-up are unclear.</p> <p>Methods</p> <p>We performed a systematic review of the literature to determine follow-up policy after PSA...

Full description

Bibliographic Details
Main Authors: Van der Meer Saskia, Löwik Sabine AM, Hirdes Willem H, Nijman Rien M, Van der Meer Klaas, Hoekstra-Weebers Josette EHM, Blanker Marco H
Format: Article
Language:English
Published: BMC 2012-10-01
Series:BMC Family Practice
Subjects:
PSA
Online Access:http://www.biomedcentral.com/1471-2296/13/100
id doaj-07981148fbe3462789c6de47ff0e4d6c
record_format Article
spelling doaj-07981148fbe3462789c6de47ff0e4d6c2020-11-25T03:40:10ZengBMCBMC Family Practice1471-22962012-10-0113110010.1186/1471-2296-13-100Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic reviewVan der Meer SaskiaLöwik Sabine AMHirdes Willem HNijman Rien MVan der Meer KlaasHoekstra-Weebers Josette EHMBlanker Marco H<p>Abstract</p> <p>Background</p> <p>Prostate specific antigen (PSA) testing is widely used, but guidelines on follow-up are unclear.</p> <p>Methods</p> <p>We performed a systematic review of the literature to determine follow-up policy after PSA testing by general practitioners (GPs) and non-urologic hospitalists, the use of a cut-off value for this policy, the reasons for repeating a PSA test after an initial normal result, the existence of a general cut-off value below which a PSA result is considered normal, and the time frame for repeating a test.</p> <p><it>Data sources</it>. MEDLINE, Embase, PsychInfo and the Cochrane library from January 1950 until May 2011.</p> <p><it>Study eligibility criteria</it>. Studies describing follow-up policy by GPs or non-urologic hospitalists after a primary PSA test, excluding urologists and patients with prostate cancer. Studies written in Dutch, English, French, German, Italian or Spanish were included. Excluded were studies describing follow-up policy by urologists and follow-up of patients with prostate cancer. The quality of each study was structurally assessed.</p> <p>Results</p> <p>Fifteen articles met the inclusion criteria. Three studies were of high quality. Follow-up differed greatly both after a normal and an abnormal PSA test result. Only one study described the reasons for not performing follow-up after an abnormal PSA result.</p> <p>Conclusions</p> <p>Based on the available literature, we cannot adequately assess physicians’ follow-up policy after a primary PSA test. Follow-up after a normal or raised PSA test by GPs and non-urologic hospitalists seems to a large extent not in accordance with the guidelines.</p> http://www.biomedcentral.com/1471-2296/13/100Prostate specific antigenPSAFollow-upGeneral practitionersNon-urologic hospitalistsGuidelinesSystematic review
collection DOAJ
language English
format Article
sources DOAJ
author Van der Meer Saskia
Löwik Sabine AM
Hirdes Willem H
Nijman Rien M
Van der Meer Klaas
Hoekstra-Weebers Josette EHM
Blanker Marco H
spellingShingle Van der Meer Saskia
Löwik Sabine AM
Hirdes Willem H
Nijman Rien M
Van der Meer Klaas
Hoekstra-Weebers Josette EHM
Blanker Marco H
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
BMC Family Practice
Prostate specific antigen
PSA
Follow-up
General practitioners
Non-urologic hospitalists
Guidelines
Systematic review
author_facet Van der Meer Saskia
Löwik Sabine AM
Hirdes Willem H
Nijman Rien M
Van der Meer Klaas
Hoekstra-Weebers Josette EHM
Blanker Marco H
author_sort Van der Meer Saskia
title Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
title_short Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
title_full Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
title_fullStr Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
title_full_unstemmed Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
title_sort prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
publisher BMC
series BMC Family Practice
issn 1471-2296
publishDate 2012-10-01
description <p>Abstract</p> <p>Background</p> <p>Prostate specific antigen (PSA) testing is widely used, but guidelines on follow-up are unclear.</p> <p>Methods</p> <p>We performed a systematic review of the literature to determine follow-up policy after PSA testing by general practitioners (GPs) and non-urologic hospitalists, the use of a cut-off value for this policy, the reasons for repeating a PSA test after an initial normal result, the existence of a general cut-off value below which a PSA result is considered normal, and the time frame for repeating a test.</p> <p><it>Data sources</it>. MEDLINE, Embase, PsychInfo and the Cochrane library from January 1950 until May 2011.</p> <p><it>Study eligibility criteria</it>. Studies describing follow-up policy by GPs or non-urologic hospitalists after a primary PSA test, excluding urologists and patients with prostate cancer. Studies written in Dutch, English, French, German, Italian or Spanish were included. Excluded were studies describing follow-up policy by urologists and follow-up of patients with prostate cancer. The quality of each study was structurally assessed.</p> <p>Results</p> <p>Fifteen articles met the inclusion criteria. Three studies were of high quality. Follow-up differed greatly both after a normal and an abnormal PSA test result. Only one study described the reasons for not performing follow-up after an abnormal PSA result.</p> <p>Conclusions</p> <p>Based on the available literature, we cannot adequately assess physicians’ follow-up policy after a primary PSA test. Follow-up after a normal or raised PSA test by GPs and non-urologic hospitalists seems to a large extent not in accordance with the guidelines.</p>
topic Prostate specific antigen
PSA
Follow-up
General practitioners
Non-urologic hospitalists
Guidelines
Systematic review
url http://www.biomedcentral.com/1471-2296/13/100
work_keys_str_mv AT vandermeersaskia prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview
AT lowiksabineam prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview
AT hirdeswillemh prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview
AT nijmanrienm prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview
AT vandermeerklaas prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview
AT hoekstraweebersjosetteehm prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview
AT blankermarcoh prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview
_version_ 1724535901488414720